Internal Medicine, Medical Oncology · Hackensack, NJ
NPI
1972746394
Since 2009
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
92 2nd St
Hackensack, NJ, 07601
Phone (551) 996-3033
Groups this clinician bills Medicare through
Medicare paid, 2024
$287K
11,254 services
Medicare patients, 2024
532
Average age 75
Drug cost, 2024
$10.6M
1,605 prescriptions
Company payments, 2025
$35K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lori A Leslie was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,087 times for 461 patients. In total Lori A Leslie billed 11,254 services in 29 codes, and Medicare paid $287K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-26.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,087 | 461 | $13.87 | $15K |
| 99214 Office E&M - Established | Office | 720 | 382 | $104.69 | $75K |
| 99215 Office E&M - Established | Office | 548 | 219 | $150.09 | $82K |
| Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | Office | 360 | 14 | $105.98 | $38K |
| 99233 Hospital E&M - Subsequent | Facility | 236 | 49 | $99.17 | $23K |
| 96372 Injection Administration | Office | 74 | 36 | $12.11 | $896 |
| 99223 Hospital E&M - Initial | Facility | 52 | 41 | $141.34 | $7,350 |
| 99205 Office E&M - New | Office | 46 | 46 | $188.99 | $8,693 |
| 99238 Hospital Discharge Management | Facility | 42 | 30 | $68.82 | $2,890 |
| 99222 Hospital E&M - Initial | Facility | 17 | 12 | $110.18 | $1,873 |
By year: 2022 $232K for 17,073 services; 2023 $261K for 11,549 services; 2024 $287K for 11,254 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 682 | 326 | $7.59 | $5,178 |
| 85027 Blood Count | 263 | 165 | $6.36 | $1,673 |
Medicare prescription drug claims, 2024
In 2024, the drug Lori A Leslie prescribed most often to Medicare patients was Brukinsa (Zanubrutinib), with 458 prescriptions and refills. In total Lori A Leslie wrote 1,605 Medicare prescriptions that cost $10.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Brukinsa Zanubrutinib | 458 | 460 | 52 | $6.4M |
| Calquence Acalabrutinib Maleate | 160 | 160 | 18 | $2.4M |
| Valacyclovir Valacyclovir Hcl | 125 | 177 | 34 | $3,609 |
| Acyclovir Generic | 116 | 158 | 33 | $1,303 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 98 | 110 | 25 | $275 |
| Prednisone Generic | 79 | 79 | 43 | $169 |
| Pantoprazole Sodium Generic | 54 | 66 | 15 | $1,635 |
| Ciprofloxacin Hcl Generic | 52 | 52 | 17 | $413 |
| Imbruvica Ibrutinib | 44 | 44 | Under 11 | $713K |
| Venclexta Venetoclax | 42 | 42 | Under 11 | $635K |
| Allopurinol Generic | 42 | 60 | 25 | $258 |
| Fluconazole Generic | 39 | 39 | 17 | $1,157 |
| Nyvepria Pegfilgrastim-Apgf | 31 | 31 | Under 11 | $117K |
| Ondansetron Hcl Generic | 27 | 27 | 20 | $133 |
| Montelukast Sodium Generic | 21 | 29 | 14 | $222 |
Brand drugs: - claims; generic drugs: 806 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lori A Leslie $35K ($35K in general payments such as food, travel and fees) from 16 companies. The largest payer was Kite Pharma, Inc. with $7,989.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.